Partnering

Curasight is building a pipeline of products based on its use of the uPAR Theranostics platform which combines improved diagnosis of certain types of cancer using uTRACE® and more targeted and efficient treatment of the tumor using its therapeutic uTREAT® product.

We are committed to pursuing our goals through finding like-minded and skilled partners and are committed to discussing potential collaborations with industry and academic players.

Partner contact: CEO Ulrich Krasilnikoff email: uk@curasight.com